Miralles, G. D., Eron, J., Gulick, R., Merigan, T., Bartlett, J. A., Melby, T., … Demasi, R. (2002). T1249-101: 14-day safety and antiviral activity of T-1249, a peptide inhibitor of membrane fusion. In ANTIVIRAL THERAPY (Vol. 7, pp. S160–S160). INT MEDICAL PRESS LTD.

Miralles, G. D., J. Eron, R. Gulick, T. Merigan, J. A. Bartlett, T. Melby, P. Sista, et al. “T1249-101: 14-day safety and antiviral activity of T-1249, a peptide inhibitor of membrane fusion.” In ANTIVIRAL THERAPY, 7:S160–S160. INT MEDICAL PRESS LTD, 2002.

Miralles GD, Eron J, Gulick R, Merigan T, Bartlett JA, Melby T, et al. T1249-101: 14-day safety and antiviral activity of T-1249, a peptide inhibitor of membrane fusion. In: ANTIVIRAL THERAPY. INT MEDICAL PRESS LTD; 2002. p. S160–S160.

Miralles, G. D., et al. “T1249-101: 14-day safety and antiviral activity of T-1249, a peptide inhibitor of membrane fusion.” ANTIVIRAL THERAPY, vol. 7, INT MEDICAL PRESS LTD, 2002, pp. S160–S160.

Miralles GD, Eron J, Gulick R, Merigan T, Bartlett JA, Melby T, Sista P, Greenberg M, Spence B, Duff F, Demasi R. T1249-101: 14-day safety and antiviral activity of T-1249, a peptide inhibitor of membrane fusion. ANTIVIRAL THERAPY. INT MEDICAL PRESS LTD; 2002. p. S160–S160.